| Date | Time | Source | Headline | Symbol | Company |
| 10/20/2015 | 7:00AM | Business Wire | Agenus to Report Third Quarter 2015 Financial Results on October 27, 2015; Conference Call to Follow | NASDAQ:AGEN | Agenus Inc |
| 10/05/2015 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 10/05/2015 | 6:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 10/05/2015 | 6:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 09/28/2015 | 8:15AM | PR Newswire (US) | Technical Report on Biotechnology Stocks -- Amgen, ZIOPHARM Oncology, Sarepta Therapeutics, CTI BioPharma, and Agenus | NASDAQ:AGEN | Agenus Inc |
| 09/24/2015 | 8:36AM | PR Newswire (US) | Health Care Stocks Technical Review -- Agenus, Esperion Therapeutics, BioScrip, Affymetrix and Alnylam Pharmaceuticals | NASDAQ:AGEN | Agenus Inc |
| 09/23/2015 | 3:43PM | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | NASDAQ:AGEN | Agenus Inc |
| 09/18/2015 | 4:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 09/11/2015 | 5:26PM | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:AGEN | Agenus Inc |
| 09/11/2015 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AGEN | Agenus Inc |
| 09/09/2015 | 7:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AGEN | Agenus Inc |
| 09/09/2015 | 7:00AM | Business Wire | Agenus Inc. Completes $115 Million Non-Dilutive Royalty Transaction with Oberland Capital | NASDAQ:AGEN | Agenus Inc |
| 09/08/2015 | 10:00AM | Business Wire | Agenus to Present at the Rodman & Renshaw 17th Annual Global Investment Conference | NASDAQ:AGEN | Agenus Inc |
| 08/21/2015 | 4:07PM | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:AGEN | Agenus Inc |
| 08/03/2015 | 4:05PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AGEN | Agenus Inc |
| 07/31/2015 | 9:30AM | PR Newswire (US) | Biotechnology Stocks on our Scanner -- Agenus, RXi Pharma, Nektar Therapeutics, Genetic Technologies, and Agios Pharma | NASDAQ:AGEN | Agenus Inc |
| 07/24/2015 | 6:03AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AGEN | Agenus Inc |
| 07/24/2015 | 1:08AM | Business Wire | GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Preventi... | NASDAQ:AGEN | Agenus Inc |
| 07/23/2015 | 7:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AGEN | Agenus Inc |
| 07/23/2015 | 7:00AM | Business Wire | Agenus Reports Second Quarter 2015 Financial Results | NASDAQ:AGEN | Agenus Inc |
| 07/20/2015 | 7:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AGEN | Agenus Inc |
| 07/20/2015 | 7:00AM | Business Wire | Agenus Acquires Novel Antibodies to Immuno-oncology Target CEACAM1 | NASDAQ:AGEN | Agenus Inc |
| 07/16/2015 | 4:00PM | Business Wire | Agenus to Report Second Quarter 2015 Financial Results on July 23, 2015; Conference Call to Follow | NASDAQ:AGEN | Agenus Inc |
| 07/08/2015 | 4:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 07/08/2015 | 4:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 07/08/2015 | 3:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 07/08/2015 | 3:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 07/08/2015 | 3:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 07/02/2015 | 2:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |
| 07/02/2015 | 2:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AGEN | Agenus Inc |